You are currently viewing Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns – CNN

Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns – CNN

The experimental drug lecanemab shows potential as an Alzheimers disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association with… [read more]

Leave a Reply